Experimentally induced attenuation of neuropeptide-Y gene expression in transgenic mice increases mortality rate following seizures

Neuroscience Letters

Volumn 287, Issue 1, 2000, Pages 61-64

  Deprato Primeaux, Stefany ^a   Holmes, Philip V ^a   Martin, Roy J ^b   Dean, Roger G ^c   Edwards, Gaylen L ^c  

^a The University of Georgia ^*  (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Epilepsy; Kainic acid; Knock down; Neuropeptide Y; Transgenic

Indexed keywords

NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; GENE EXPRESSION; GENE FUNCTION; MALE; MORTALITY; MOUSE; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SEIZURE SUSCEPTIBILITY; TRANSGENIC MOUSE;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; KAINIC ACID; MALE; MICE; MICE, TRANSGENIC; NEURONS; NEUROPEPTIDE Y; RNA, MESSENGER; SEIZURES;

EID: 0342858974     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01137-X     Document Type: Article

References (16)

1. Baraban S.C., Hollopeter G., Erickson P.A., Schwartzkroin P.A., Palmiter R.D. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. Neuroscience. 17:1997;8927-8942.
2. Broqua P., Wettstein J.G., Rocher M.N., Gauthier-Martin B., Junien J.L. Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav. Pharm. 6:1995;215-222.
3. Dean R.G., Hulsey M., Brackett B.G., Rzucidlo J., Martin R.J., Baile C., Edwards G.L. Tissue specific tetracycline responsive neuropeptide Y expression in transgenic mice. Soc. Neurosci. Abs. 23:1997;1483.
4. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381:1996;415-418.
5. Flood J.F., Morley J.E. Increased food intake by neuropeptide Y is due to an increased motivation to eat. Peptides. 12:1991;1329-1332.
6. Gingrich J.R., Roder J. Inducible gene expression in the nervous system of transgenic mice. Annu. Rev. Neurosci. 21:1998;377-405.
7. Hendry S.H.C., Jones E.G., DeFelipe J., Schmechel D., Brandon C., Emson P.C. Neuropeptide-containing neurons of the cerebral cortex are also GABAergic. Proc. Natl. Acad. Sci. USA. 81:1984;6526-6530.
8. Heilig M., McLeod S., Brot M., Heinrichs S.C., Menzaghi F., Koob G.F., Britton K.T. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology. 8:1993;357-363.
9. Heilig M., Widerlov E. Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses. Acta Psychiatr. Scand. 82:1990;94-114.
10. Huhman K.L., Babagbemi T.O., Albers H.E. Bicuculline blocks neuropeptide Y-induced phase advances when microinjected in the suprachiasmatic nucleus of Syrian hamsters. Brain Res. 675:1995;333-336.
11. Larhammar D., Ericsson A., Persson H. Structure and expression of the rat neuropeptide Y gene. Proc. Natl. Acad. Sci. USA. 84:1987;2068-2072.
12. Montemurro D.G., Dukelow R.H. A Stereotaxic Atlas of the Diencephalon and Related Structures of the Mouse. 1972;Futura, New York.
13. Nakajima A., Inui A., Asakawa A., Momose K., Ueno N., Teranishi A., Baba S., Kasuga M. Neuropeptide Y produces anxiety via Y2-type receptors. Peptides. 19:1998;359-363.
14. Sperk G., Lassmann H., Baran H., Kish S.J., Seitelberger F., Hornykiewicz O. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience. 10:1983;1301-1315.
15. Woldbye D.P.D., Larsen P.J., Mikkelsen J.D., Klemp K., Madsen T.M., Bolwig T.G. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5 like receptors. Nat. Med. 3:1997;761-764.
16. Woldbye D.P.D., Madsen T.M., Larsen P.J., Mikkelsen J.D., Bolwig T.G. Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res. 737:1996;162-168.